Amit Kumar, an Indian journalist based in the eastern state of Bihar, received a tip in 2009 from a village called Manan Bigha just two kilometers away from his home. There was a man there dying from starvation, he was told. The situation was urgent. Mr. Kumar rushed off to visit the man, Kangresh Manjhi, and exhaustively documented his story. He learned how Mr. Manjhi, a lower-caste, landless laborer, was forced...
More »SEARCH RESULT
On the Recent Poverty Estimates-Himanshu
An unnecessary controversy has been started by the release of the poverty estimates of 2009-10 by the planning commission. The controversy, which was entirely avoidable, was allowed to go on because of the poor handling of the issue by the planning commission. It is unfortunate that the planning commission was less than willing to own the Tendulkar committee report which was submitted in December 2009 and accepted by the commission...
More »Germany strikes deal to tax secret Swiss accounts by David Jolly
—New York Times News Service Switzerland has agreed to a revised tax deal with Germany, with Switzerland to pay billions of dollars on funds hidden in its banks by German tax dodgers. The deal was the latest step in an international charm offensive that is meant to salvage at least some of Switzerland's famous banking secrecy. The accord, which was tougher to reach after a deal in September was criticised by German...
More »The great and infuriating poverty debate-Saugato Datta
The debate over the poverty numbers in India is oddly impoverished. Judging from the vociferousness with which India’s press and English-speaking upper-middle-classes are debating the latest poverty figures, those who chide the wealthy for a lack of concern for the poor are barking up the wrong tree. And no doubt much of the breast-beating about the “absurd” poverty cutoffs and the declines in poverty (exaggerated! inadequate!) is extremely well-intentioned. Unfortunately, the...
More »Natco Pharma bags licence to sell Bayer's cancer drug Nexavar
-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision. The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...
More »